- Hem
- Om universitetet
- Hitta person
- Charlotte Andersson
Charlotte Andersson
Anknuten till forskning
Avd för medicinskOm Charlotte Andersson
Charlotte Andersson disputerar inom ämnet medicinsk strålningsvetenskap, den 1 juni 2022
Titeln på hennes avhandling är - Optimisation of radionuclide therapy by reduction of normal tissue damage
Läs en kort populärvetenskaplig sammanfattning om avhandlingen - Radioaktiva läkemedel kan angripa spridd cancer
-
Effect of Antioxidant rA1M on Expression of Apoptosis and Oxidative-Stress-Related Genes
during 177Lu-Octreotate Treatment of GOT1 Neuroendocrine
Tumours
Nishte Dello, Charlotte Andersson, Daniella Pettersson, Amin Al-awar, Emman Shubbar, B. Åkerström, M. Gram, Eva Forssell-Aronsson
5th European Radiation Protection Week. Book of Abstracts. Vienna, Austria, 2021, 22-25 November, p. 58 - 2021 -
Effects of rA1M on the regulation of apoptotic related genes in kidney medulla after 177Lu-octreotate injection in
mice
Klara Simonsson, Charlotte Andersson, Emman Shubbar, Britta Langen, Bo Åkerström, Magnus Gram, Khalil Helou, Eva Forssell-Aronsson
5th European Radiation Protection Week. Book of Abstracts. Vienna, Austria, 2021, 22-25 November. - 2021 -
Biodistribution of I-131 in mice is influenced by circadian
variations
Charlotte Andersson, Mikael Elvborn, Johan Spetz, Britta Langen, Eva Forssell-Aronsson
Scientific Reports - 2020 -
Coadministration of three antioxidants did not influence the tumour response to radiotherapy in GOT1 neuroendocrine tumour
model
Charlotte Andersson, Emman Shubbar, Lukas Lundholm, Bo Åkerström, Magnus Gram, Khalil Helou, Eva Forssell-Aronsson
Digital ERRS2020 - 2020 -
rA1M, a kidney protector during
PRRT?
Charlotte Andersson, Emman Shubbar, Bo Åkerström, Magnus Gram, Eva Forssell-Aronsson
European Radiation Protection Week, Stockholm, Sweden, 2019, 14-18 October - 2019 -
Chronotherapy: a possible way to optimze 131I-based
therapy?
Charlotte Andersson, Mikael Elvborn, Johan Spetz, Britta Langen, Eva Forssell-Aronsson
European Radiation Protection Week, Stockholm, Sweden, 2019, 14-18 October - 2019 -
The protective antioxidant rA1M allows full antitumor effects of 177Luoctreotate
treatment in PDX neuroendocrine tumor
models
Charlotte Andersson, Emman Shubbar, Emil Schüler, Bo Åkerström, Magnus Gram, Eva Forssell-Aronsson
Gothenburg Cancer meeting, Gothenburg, Sweden, 2019, May 6-7 - 2019 -
Recombinant alpha(1)-Microglobulin Is a Potential Kidney Protector in Lu-177-Octreotate Treatment of Neuroendocrine
Tumors
Charlotte Andersson, Emman Shubbar, E. Schuler, B. Akerstrom, M. Gram, Eva Forssell-Aronsson
Journal of Nuclear Medicine - 2019 -
Co-administration of rA1M during 177Lu-octreotate treatment does not
interfere with the therapeutic
effect
Charlotte Andersson, Emman Shubbar, Bo Åkerström, Magnus Gram, Eva Forssell-Aronsson
The North American Neuroendocrine Tumor Society, Seattle, 2018, Oktober 4-6 - 2018 -
Potential protection of renal function in 177Lu-octreotate treatment
using
alpha-1-microglobulin
Charlotte Andersson, Emman Shubbar, Bo Åkerström, Magnus Gram, Eva Forssell-Aronsson
The European Association of Nuclear Medicine , Düsseldorf, 2018, Oktober 13-17 - 2018 -
Kidney protection during treatment with 177Lu-octreotate using
recombinant alpha-1-microglobulin
Charlotte Andersson, Emman Shubbar, Bo Åkerström, Magnus Gram, Eva Forssell-Aronsson
The Swedish Radiation Research Association for young Scientists Workshop , Uppsala, 2018, Augusti 29-31 - 2018 -
A1M is a potential kidney protector in 177Lu-octreotate treatment of neuroendocrine
tumours
Charlotte Andersson, Emman Shubbar, Bo Åkerström, Magnus Gram, Eva Forssell-Aronsson
2nd European Congress of Medical Physics, Köpenhamn, 2018, Augusti 23-25 - 2018 -
Sex-dependent absorbed doses from 131I in male and female
mice
Mikael Elvborn, Charlotte Andersson, Johan Spetz, Britta Langen, Eva Forssell-Aronsson
63rd Annual Meeting of the Radiation Research Society, Cancun, Mexico - 2017 -
Circadian rhythm: a factor influencing biodistribution of 131I in
mice
Charlotte Andersson, Mikael Elvborn, Johan Spetz, Britta Langen, Eva Forssell-Aronsson
63rd Annual Meeting of the Radiation Research Society, Cancun, Mexico - 2017 -
The influence of biological sex on thyroid cancer treatment risk
assessment
Mikael Elvborn, Charlotte Andersson, Johan Spetz, Britta Langen, Eva Forssell-Aronsson
Swedish Cancer Research Meeting, Gothenburg, 2016, November 7-8 - 2016 -
Sex-dependence in absorbed dose from I-131 in
mice
Mikael Elvborn, Charlotte Andersson, Johan Spetz, Britta Langen, Eva Forssell-Aronsson
Höstmöte med Cancerfondens Planeringsgrupp för Onkologisk Radionuklidterapi, Uppsala, 2016, November 24-25 - 2016 -
Diurnal variations in biodistribution of the radionuclide I-131 in
mice
Charlotte Andersson, Mikael Elvborn, Johan Spetz, Britta Langen, Eva Forssell-Aronsson
Swedish Cancer Research Meeting, Gothenburg, 2016, November 7-8 - 2016 -
Diurnal variations in biodistribution of the radionuclide I-131 in
mice
Charlotte Andersson, Mikael Elvborn, Johan Spetz, Britta Langen, Eva Forssell-Aronsson
Swedish Cancer Fund's planning group for oncological radionuclide therapy, Uppsala, Sweden, Nov 24-25, 2016 - 2016 -
The influence of circadian rhythm on the biodistribution of
I-131
Charlotte Andersson, Mikael Elvborn, Johan Spetz, Britta Langen, Eva Forssell-Aronsson
Swedish Radiation Research Association for Young Scientists Workshop, Stockholm, 2016, August 25-26 - 2016